Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CD07805/47 Gel for Facial Erythema in Rosacea
NCT01355471Phase 3Completed
- Sponsor
- Galderma
- Start
- May 2011
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of brimonidine transdermal lotion in rosacea, sponsored by Galderma. Started May 2011; status: completed.
02
Drugs
brimonidine transdermal lotion
03
Conditions
rosacea
Beyond the preview
Go deeper on NCT01355471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01355471.